About Geneme
Geneme is a Healthcare company based in Gdansk (Poland) founded in 2018. Genetic tests for disease diagnostics are developed using PCR technology. Geneme has raised $6.33 million across 1 funding round from investors including Robin Tombs. Geneme offers products and services including qPCR Diagnostic Kits, SNPs Kits, STIs Kits, and IDs Kits. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its legal entity is GENEME SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ.
Company details
Geneme was founded in 2018 in Gdansk, Poland, within the biotechnology sector. Diagnostic tests for diseases are developed by the company, focusing on genetic analysis. Real-time PCR technology is employed to duplicate specific DNA sequences, followed by the use of DNA probes to identify relevant genetic variants. Operations center on creating tools for accurate disease diagnosis, serving healthcare applications in Europe.
- Total Equity Funding$6.33M (USD)
in 1 rounds
- Latest Funding Round$6.33M (USD), Angel Round
Dec 2020
Products & Services of Geneme
Geneme offers a comprehensive portfolio of products and services, including qPCR Diagnostic Kits, SNPs Kits, STIs Kits, and IDs Kits.
Kits for genetic analysis in laboratory settings
Tools for detecting Single Nucleotide Polymorphisms
Kits for identifying Sexually Transmitted Infections
Solutions for diagnosing Infectious Diseases
Funding Insights of Geneme
Geneme has successfully raised a total of $6.33M through 1 strategic funding round. The most recent funding activity was a Angel Round of $6.33 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.33M
- Total Rounds 1
- Last Round Angel Round — $6.33M
- First Round $6.33M
(Dec 2020)
- Investors Count 1
All 1 funding rounds of Geneme with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2020 | $6.33M | Angel Round | – | Robin Tombs | – |
1 investors in total: 0 institutional and 1 angel.
Investors in Geneme
Geneme has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Robin Tombs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
RT Robin Tombs | Co-founder of Yoti, angel investor, focused on tech and identity solutions | unknown_45d222a56c474d32a |
Investor details for Geneme
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Geneme
2 dated milestones of Geneme across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Geneme is founded.
- Funding First funding round of $6.3M.
Web traffic of Geneme
The website of Geneme (geneme.eu) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 22.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Geneme
Complete news archive for Geneme
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geneme
Geneme was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Geneme is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.
Geneme is a funded company, having raised a total of $6.33M across 1 funding round to date. The company's 1st funding round was a Angel Round of $6.33M, raised on Dec 2020.
Geneme was founded in 2018 in Gdansk, Poland, within the biotechnology sector. Diagnostic tests for diseases are developed by the company, focusing on genetic analysis. Real-time PCR technology is employed to duplicate specific DNA sequences, followed by the use of DNA probes to identify relevant genetic variants. Operations center on creating tools for accurate disease diagnosis, serving healthcare applications in Europe.
Geneme offers qPCR Diagnostic Kits, SNPs Kits, STIs Kits, and IDs Kits.
Geneme has 1 investor. Key investors include Robin Tombs.
Geneme operates through Geneme Spółka Z Ograniczoną Odpowiedzialnością.